Cervical cancer is responsible for about 270,000 deaths each year and it affects 490,000 new women every year. Screening programs are crucial for saving the lives of people that are suffering from cancer. The new screening method is a lifesaver since it is effective in preventing cervical cancer, also vaccination provided to kids to protect against HPV is gaining momentum in England.
A new health service rolled out a new screening method that detects HPV (human papillomavirus- that is responsible for cervical cancers and also in other genital areas, such as the vagina, vulva, penis, and anus) first and only those with the virus are further examined for abnormal cells. It means that any symptoms of infection can be detected sooner before cancer progresses. Research also showed that the new method takes up far more precancerous lesions than the old. Almost 83.8 percent of girls completed the two-dose HPV vaccination course in 2017/18. The national NHS HPV vaccination program currently uses the Gardasil vaccine which protects against four types of HPV that cause most cancer cases.
Last year, researchers said cervical cancer could be effectively eliminated in most countries around the world by the end of the 21st Century thanks to the jab and improved screening. Professor Peter Johnson, the NHS’s national clinical director for cancer, said, “It is vitally important that all eligible people attend for their screening appointments, to keep themselves safe. Combined with the success of the HPV vaccine for both boys and girls, we hope that cervical cancer can be eliminated altogether by the NHS in England. The chances of surviving cancer are at a record high, but there is always more we can do, as we continue to deliver our Long Term Plan.”
Robert Music, chief executive of Jo’s Cervical Cancer Trust, said: “It is exciting that we are seeing advances in cervical cancer prevention and must continue to look to the future to make sure our cervical screening program continues to adapt and evolve. Preventing cervical cancer using the new screening method seems to be ‘door-opening’ new cancer therapy.